Core Viewpoint - The company, Tengsheng Bo Pharmaceutical-B (02137.HK), announced the granting of 600,000 stock options to assignees under the 2023 stock option plan, pending acceptance by the assignees [1] Summary by Relevant Sections - Stock Options Granted - The company will grant 600,000 stock options to assignees, subject to their acceptance [1] - Current Share Information - As of the announcement date, the total number of issued shares is 720,936,585 (excluding treasury shares) [1] - Impact of Stock Options - If all granted stock options are exercised, the new shares will represent approximately 0.08% of the total issued shares as of the announcement date (excluding treasury shares) and approximately 0.08% of the enlarged total issued shares (excluding treasury shares) [1]
腾盛博药-B(02137.HK)授出60万份购股权